Elevation of IGF-2 receptor and the possible underlying implications in end-stage heart failure patients before and after heart transplantation.
about
Biological functionalization of drug delivery carriers to bypass size restrictions of receptor-mediated endocytosis independently from receptor targeting.Doxorubicin attenuates CHIP-guarded HSF1 nuclear translocation and protein stability to trigger IGF-IIR-dependent cardiomyocyte death.Renin and the IGFII/M6P receptor system in cardiac biology.
P2860
Elevation of IGF-2 receptor and the possible underlying implications in end-stage heart failure patients before and after heart transplantation.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Elevation of IGF-2 receptor an ...... d after heart transplantation.
@ast
Elevation of IGF-2 receptor an ...... d after heart transplantation.
@en
type
label
Elevation of IGF-2 receptor an ...... d after heart transplantation.
@ast
Elevation of IGF-2 receptor an ...... d after heart transplantation.
@en
prefLabel
Elevation of IGF-2 receptor an ...... d after heart transplantation.
@ast
Elevation of IGF-2 receptor an ...... d after heart transplantation.
@en
P2093
P2860
P1476
Elevation of IGF-2 receptor an ...... d after heart transplantation.
@en
P2093
Chuanjue Cui
Shengshou Hu
Xiaoling Zhang
Yingjie Wei
P2860
P304
P356
10.1111/J.1582-4934.2011.01414.X
P577
2012-05-01T00:00:00Z